Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases
Key Points
Key points are not available for this paper at this time.
Abstract
ClinicalTrials.gov Identifier: NCT03074656.
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases | Synapse